Generics and Biosimilars are the Keys to Lower Drug Prices ByEdward Longe October 15, 2021June 3, 2022
ACI Joins Coalition Letter in Support of Biosimilar Competition BySteve Pociask July 1, 2021July 1, 2021
Coalition Letter Calls for the Use of Lower-Cost Biosimilars BySteve Pociask November 24, 2020November 24, 2020
THE HILL: Public Quality Standards for Biologic Drugs Promote Transparency and Competition; Don’t Get Rid of Them ByLiam Sigaud July 23, 2019August 15, 2019
Regulatory Uncertainty and Industry Practices Force Consumers to Overpay on Biologics ByAlan Daley February 19, 2019
Coalition Sends Letter to FDA: Foster Biosimilar Competition and Reduce Costs Byeditor September 21, 2018September 21, 2018
